Removal of colorectal adenomas during colonoscopy reduces the incidence of colorectal carcinoma (CRC) and CRC-related mortality [1 -4]. Despite surveillance of patients after resection of adenomas [5] the risk of developing CRC remains higher than in the general population [6]. Moreover, it is known that CRC can be detected in the interval between scheduled surveillance colonoscopies [7]. One of the important causes for interval carcinomas is incomplete removal of the original adenoma [8 -10]. As residual adenomatous tissue has been shown to be capable of rapid regeneration [11, 12] , incomplete resection may result in local recurrence [13] . Several studies have indicated that incomplete removal contributes to a higher subsequent incidence of CRC [5, 9, 14 -16].
Introduction

!
Removal of colorectal adenomas during colonoscopy reduces the incidence of colorectal carcinoma (CRC) and CRC-related mortality [1 -4]. Despite surveillance of patients after resection of adenomas [5] the risk of developing CRC remains higher than in the general population [6] . Moreover, it is known that CRC can be detected in the interval between scheduled surveillance colonoscopies [7] . One of the important causes for interval carcinomas is incomplete removal of the original adenoma [8 -10] . As residual adenomatous tissue has been shown to be capable of rapid regeneration [11, 12] , incomplete resection may result in local recurrence [13] . Several studies have indicated that incomplete removal contributes to a higher subsequent incidence of CRC [5, 9, 14 -16].
Concerns regarding local recurrence exist mostly for lesions with nonpedunculated morphology, which are often removed by endoscopic mucosal resection (EMR) with submucosal fluid injection. The issue of residual tissue seems to be more pronounced after piecemeal resection, which is at least in part due to the difficult histologic evaluation of resection margins when lesions are resected in pieces. To reduce the risk of interval carcinomas secondary to local recurrence after EMR, international guidelines recommend that follow-up colonoscopy is performed 2 -12 months after endoscopic resection of flat and sessile lesions [5, 17] . The recommended time interval for the first follow-up colonoscopy varies within and between guidelines, depending on size, morphology, and resection method used. Currently, there is no strong evidence pointing to specific risk factors for local Background and study aims: Local recurrence has been observed after endoscopic mucosal resection (EMR) of nonpedunculated colorectal lesions. The indications for follow-up colonoscopy and the optimal time interval are currently unclear. The aims of this systematic review were to assess the frequency of local recurrence after EMR, to identify risk factors for recurrence, and to provide follow-up recommendations. Methods: A literature search was performed in PubMed, EMBASE, and the Cochrane Library. EMR was defined as endoscopic snare resection after submucosal fluid injection for removal of nonpedunculated adenomas and early carcinomas. Local recurrence was subdivided into early recurrence (detected at the first follow-up colonoscopy) and late recurrence (detected after ≥ 1 previous normal colonoscopy). A random effects meta-analysis was performed to calculate the pooled estimate of risk of recurrence.
Results: A total of 33 studies were included. The mean recurrence risk after EMR was 15 % (95 % confidence interval [CI] 12 % -19 %). Recurrence risk was higher after piecemeal resection (20 %; 95 %CI 16 % -25 %) than after en bloc resection (3 %; 95 %CI 2 % -5 %; P < 0.0001). In 15 studies that differentiated between early and late recurrences, 152/173 recurrences (88 %) occurred early. In four studies with follow-up at 3, 6, and ≥ 12 months, 19/25 (76 %) recurrences were detected at 3 months, increasing to 24 (96 %) at 6 months. In multivariable analysis, only piecemeal resection was associated with recurrence (3 of 3 studies). Conclusion: Local recurrence after EMR of nonpedunculated colorectal lesions occurs in 3 % of en bloc resections and 20 % of piecemeal resections. Piecemeal resection was the only independent risk factor for recurrence. As more than 90 % of recurrences are detected at 6 months after EMR, we propose that 6 months is the optimal initial follow-up interval.
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recurrence, nor is advice for appropriate intervals of follow-up available. By performing a systematic review and meta-analysis we aimed to assess the magnitude of the problem of local recurrence after EMR of flat and sessile adenomas and minimally invasive carcinomas. Secondary aims were to identify risk factors for local recurrence and to determine the optimal timing for the first followup endoscopy after EMR, in order to individualize recommendations for surveillance.
Methods
!
This systematic review was conducted and reported according to the preferred reporting items for systematic reviews and metaanalyses (PRISMA) statement [18] .
Eligibility criteria and definitions
Studies were eligible for inclusion if they were prognostic or therapeutic follow-up studies that reported on local recurrence after EMR of nonpedunculated colorectal lesions. Study designs included both prospective and retrospective cohort studies, casecontrol studies, and therapeutic clinical trials. Feasibility studies for new removal techniques were only included if the technique resembled conventional EMR. Conventional EMR was defined as snare resection after submucosal fluid injection for nonpedunculated lesions. Resected lesions included adenomas with low grade dysplasia (LGD) or high grade dysplasia (HGD) or minimally invasive mucosal or submucosal carcinomas, particularly Sm1 (invasion of submucosa < 1 mm). As in situ carcinoma of the colorectum is not always considered a distinct entity, no distinction was made between HGD and in situ carcinoma. Local recurrence as an outcome implies that patients were followed up by undergoing at least one colonoscopy after the index procedure. Local recurrence was defined by the criteria of Higaki et al. [19] : lesions reappearing at the site that was previously treated endoscopically, lesions with convergent folds, and lesions with no convergent folds but with a clear polypectomy ulcer scar nearby were regarded as locally recurrent tumors. Local recurrence was divided into early recurrence (found at first follow-up colonoscopy) and late recurrence (found after at least one previous normal colonoscopy). Successful treatment was defined as complete clearance of all adenomatous or carcinomatous tissue, allowing for an unlimited number of endoscopic treatments but not surgery.
Information sources and search strategy
The electronic databases of PubMed, EMBASE, and Cochrane were searched for articles published in the English language between January 2000 and September 2012. The search term comprised synonyms for "colonoscopic resection of colorectal lesions" as domain and "local recurrence" as outcome (see Appendix e1, available online).
Study selection
After removing duplicate studies, titles and abstracts were screened for study design and domain. If full texts were available, articles were subsequently assessed in more detail for descriptions of domain and outcome (• " Fig. 1 ).
Selected full text articles were critically appraised for relevance and validity. In order for articles to be considered relevant, at least 80 % of the reported procedures had to be EMRs performed using submucosal fluid injection, or resections without submucosal fluid injection had to be reported separately. Furthermore, studies were only deemed relevant if separate recurrence rates were given or derivable for nonpedunculated vs. pedunculated lesions, adenomas and minimally invasive carcinomas vs. deep submucosal carcinomas ( ≥ Sm2), and en bloc vs. piecemeal resections (see Table e1 , available online). For the latter, it was also sufficient for the ratio of en bloc and piecemeal resected lesions in follow-up to be reported. If outcomes were not reported or were unclear, authors were contacted by email. If no additional information was provided, studies were excluded from the review and meta-analysis. Studies were scored for validity based on potential biases, according to the criteria adapted from Hayden et al. (see Table e2 , available online) [20] . As this review comprised both prognostic and therapeutic studies, the focus was on study participation, study attrition, and outcome reporting.
Data extraction and statistical analyses
The risk of recurrence of nonpedunculated colorectal adenomas or minimally invasive carcinomas was extracted from the selected articles.
A meta-analysis for the risk of recurrence was performed using a random effects model. Cochran's Q test was performed to test for heterogeneity between studies and between recurrence rates after en bloc and piecemeal resections. A P value of < 0.05 was considered significant. All statistical analyses were conducted using R version 2.15.2 (The R Foundation for Statistical Computing, Vienna, Austria).
Results
!
Study selection
After screening titles, abstracts, and full text articles, 45 eligible studies were identified (• " Fig. 1 ) [19, 21 -24] and assessed for relevance (see Table e1 , available online). Of these studies, a total of 12 were excluded, either because no separate assessment of recurrences was made for nonpedunculated vs. pedunculated lesions [21 -25] , deep submucosal lesions vs. non-or minimally invasive lesions [24 -27] or en bloc vs. piecemeal resections [21 -31] , or because submucosal fluid injection was not reported to be used for more than 80 % of resections [27, 31, 32] . One study reported no separate recurrence rates for en bloc and piecemeal resections but instead provided the ratio of en bloc and piecemeal lesions at follow-up [33] .
Risk of bias in each study
A total of 33 relevant studies were critically appraised for potential bias in relation to the outcome of interest (see Table e2 , available online). For six studies, the risk of bias was found to be very small. The risk of bias was considered small in 11 studies and moderate in 16 studies. As there were no relevant studies with a high risk of bias, none of these studies were excluded based on validity.
Study characteristics
The 33 included studies comprised 28 cohort studies and case series (8 prospective [19, 40, 41, 43, 45, 46, 48, 50] [46] . A total of 22 studies reported separate results for en bloc and piecemeal resections, and 10 studies focussed on piecemeal resection. One study reported combined results, but provided the ratio of en bloc and piecemeal resected lesions at follow-up. Additional use of argon plasma coagulation (APC) to complete EMR was reported in 17 studies.
As histologic assessment of resection margins after piecemeal resection is practically infeasible if not impossible, information on resection margins was generally not given for piecemeal resected lesions. Of the 23 studies taking into account both en bloc and piecemeal resections, 9 reported on the resection margins, of which only 5 reported this specifically for lesions at follow-up. Almost all en bloc resections appeared to have been radical (• " Table 3).
Follow-up
In most studies the initial follow-up interval was 3 -6 months. A total of 10 studies allowed the first follow-up colonoscopy to be performed at a later stage. In 23 studies providing a mean and/ or a median follow-up, the overall mean was 23 months. [33] is not included in this figure, as it was not clear how many of the recurrences were found after en bloc vs. piecemeal resection.
Risk of recurrence and treatment success
Overall, the mean risk of recurrence after EMR in the 33 studies was 15 % (95 % confidence interval [CI] 12 % -19 %). In these studies, 31 % of lesions had been resected en bloc. The pooled estimate of recurrence risk was significantly higher for piecemeal resections (20 %; 95 %CI 16 % -25 %) than for en bloc resections (3 %; 95 %CI 2 % -5 %; Cochran's Q test P < 0.0001) (• " Fig. 2 ).
Of the 351 recurrences that were reported to be re-treated at follow-up endoscopy, 75 (21 %) recurred again. Modalities used for retreatment were APC and/or EMR. After a mean of 1.2 endoscopic re-treatments, successful eradication was achieved in 91.4 % of recurrences. Overall, endoscopic treatment was successful for 99 % of all lesions for which EMR was initially considered adequate, meaning that for 1 % of these lesions surgical resection was eventually necessary. The mean number of endoscopic treatments needed to eradicate index lesions was also 1.2.
Early and late recurrence and optimal follow-up interval 
Risk factor analysis
In studies performing univariable analysis, size, piecemeal resection, and non-R0 resections were reported to be associated with local recurrence in 10 of 12 studies, 6 of 9 studies, and 2 of 2 studies, respectively (• " Table 4 ; • " Fig. 4) . Of the 12 studies that univariably assessed the association between size and recurrence, three used a continuous variable and nine used varying categories with thresholds between 20 and 40 mm. Three studies showed that an increasing number of resected fragments per lesion correlated with the risk of recurrence in univariable analysis. Two studies reported that in case of free resections margins, the risk of recurrence was indeed very small. Apart from size, lesion characteristics were not found to affect the recurrence risk. Location was not associated with recurrence in any of the studies. Four studies showed that recurrence was not found more often after resection of flat lesions compared with sessile lesions. For laterally spreading tumors (LSTs), the granular form was associated with recurrence in two of four studies in univariable analysis. Classification of lesions at histology was not uniformly tested in different studies and was rarely associated with recurrence. APC had a protective effect in one study when applied routinely after endoscopically complete EMR [39] . Additional APC treatment for macroscopic residual tissue was not a risk factor for recurrence in five studies. In multivariable analysis, only piecemeal resection was found to be associated with recurrence (in 3 of 3 studies) (• " Fig. 5 ). Size remained a risk factor in only one of four studies that reported a multivariate analysis. One of two studies reported that flat morphology was associated with recurrence.
Discussion
!
The results of this systematic review and meta-analysis show that recurrence after piecemeal EMR occurs in 20 % of lesions compared with only 3 % after en bloc EMR. Most recurrences were found during the first follow-up colonoscopy, irrespective of timing. In the few studies performing follow-up colonoscopy at regular intervals, three-quarters of recurrences were found at 3 months, increasing to more than 90 % at 6 months. Piecemeal resection was the only risk factor that was associated with recurrence in multivariable analysis.
A difference in recurrence rates between en bloc and piecemeal resections was anticipated. The decision by the endoscopist to perform the resection in piecemeal fashion is dependent on the difficulty of the resection. Reasons for performing piecemeal EMR instead of en bloc EMR are size above 20 -30 mm, location near colonic folds, or a lesion covering a large part of the lumen circumference. The outcome of this meta-analysis therefore must not be interpreted as a comparison between the two techniques, but as an indication that en bloc and piecemeal resected lesions are indeed different with regard to recurrence risk and therefore require different follow-up strategies.
As there is an intrinsic association between larger size and piecemeal resection, an attempt was made to determine the extent to which lesion size might have influenced the high recurrence rate after piecemeal resection. Ideally, raw data would have been used to see whether both size above 20 mm and resection in multiple fragments are independent risk factors for recurrence. However, this was not possible, so instead a meta-analysis was performed on lesions larger than 20 mm (• " Fig. 6 ), and this showed that the recurrence rate for piecemeal resections (22 %) was still higher than for en bloc resections (3 %; Cochran's Q test P < 0.001). It seems that piecemeal resection is a more useful clinical predictor for recurrence than size > 20 mm. When analyzing three different categories of mean or median lesion size (10 -20 mm, 20 -30 mm, and > 30 mm) with regard to recurrence after piecemeal resection, no significant differences were found (18 %, 19 %, and 19 %, respectively; Cochran's Q test P = 0.88). Studies with inclusion of lesions > 20 mm had no significantly higher risk of recurrence compared with studies that also included smaller lesions (22 % vs. 18 %; Cochran's Q test P = 0.37).
Results in the en bloc group were heterogeneous. However, the only studies finding recurrence risks above 10 % were considered Original article 1 'Both' means that en bloc and piecemeal resections were performed within the study. The percentage of lesions for which submucosal fluid injection was used is only given if it was not 100 %.
2 En bloc resection with free margins at first endoscopic resection.
3
Early: early recurrence, at first follow-up colonoscopy 4
Late: late recurrence, after at least one previous normal follow-up colonoscopy 5 The first follow-up colonoscopy was performed in 86 % of patients within 6 months.
6
In some cases of more advanced disease, first follow-up at less than 3 months.
7
Of 158 en bloc resected lesions at baseline, 151 had been resected completely.
8
Follow-up at these moments was only performed for lesions containing high grade dysplasia or cancer, or lesions resected in piecemeal fashion.
9
First follow-up after mean of 8 ± 6 months. 10 Length of follow-up was only reported for the recurring lesions: 27 ± 18 months (range 13 -69).
11
At baseline there were 140 en bloc and piecemeal resections, of which 46 showed free resection margins. 12 No distinction was made between en bloc and piecemeal. 50 margins were unidentified. 13 10 recurrences were found between 3 and 9 months, 6 were found after 12 months.
14 No distinction was made between en bloc and piecemeal resections. For at least 31 piecemeal resections margins were not free, as opposed to at least 9 en bloc resections. 15 5 recurrences were found between 1 and 5 months, 1 was found after 12 months. 16 The total number of lesions in follow-up was 423, but the sum of en bloc and piecemeal resections is 419. No reason was given for this discrepancy.
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4
Resection margins not free at histological assessment.
5
Only when used in addition to endoscopically complete EMR.
6
Size over 20 mm was reported to be directly related to piecemeal resection.
7
Advanced neoplasia was either advanced adenoma or carcinoma.
8
High negative predictive value (NPV) of free resection margins.
9
High NPV of free resection margins. 10 When size was analyzed in subgroups of piecemeal and en bloc it was a significant risk factor, as was piecemeal in 3 categories of size (1 -3, 2 -3, and > 3 cm).
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to be small [38, 50] . Bories et al. [38] included only lesions with HGD at follow-up, which may partly explain the high proportion of residual lesions. It is not possible to clarify reasons for the high recurrence risk in the study by Katsinelos et al. [50] , other than chance. The overall risk of recurrence after en bloc EMR was very low, and when the Katsinelos study [50] was excluded, the results within the en bloc group were indeed homogeneous.
Results within the piecemeal group were also clearly heterogeneous. A multivariable Poisson regression analysis was performed to identify which study-and population-related factors might explain this heterogeneity. This analysis showed a significant trend towards a decrease in recurrence rates over time, as indicated by the year of the studies. Prospective studies showed lower recurrence rates than retrospective studies. These findings provide a partial explanation for the variation in recurrence rates after piecemeal resection and may indicate an improvement of the endoscopic piecemeal resection technique over time and a lower recurrence rate when performed with a predetermined focus on complete removal. One other systematic review has reported on early and late recurrence after piecemeal EMR for colorectal lesions [65] . Barendse et al. found an early recurrence rate of 11.2 %, which is comparable to our overall recurrence of 15 %. In a recent study by Pohl et al., biopsies taken from the resection margins after macroscopically complete hot snare resection showed residual tissue in 10 % of cases [66] . Although the intervention and outcome measure in that study were not completely the same as in the current metaanalysis, the results indicate a comparable risk of residual tissue after endoscopic resection. The high percentage of lesions successfully eradicated by performing an unlimited number of additional endoscopic procedures proves that most recurrences do not require surgical treatment. However, this treatment success was calculated for lesions for which attempted endoscopic treatment was considered sufficient for eradication in the first place. Therefore, the outcome is highly dependent on the endoscopist making the decision to perform only follow-up colonoscopy or additional surgical treatment after the first endoscopic treatment. Data on the earliest possible detection of recurrence are scarce and therefore strong recommendations regarding timing of follow-up colonoscopy cannot be made. However, it is clear from the current results that recurrences are not always detected at the first follow-up colonoscopy. Anecdotal evidence shows that it is not unusual for recurrences to be found after a normal follow-up colonoscopy at 3 months. Therefore, we recommend not to solemnly rely on the outcome of a colonoscopy at 3 months, but to perform follow-up colonoscopy at 6 and/or 12 months in all cases. Risk factors were only assessed in a descriptive way because a complete set of raw data was not available. A convincing majority of studies showed that size was associated with recurrence in univariable analysis. However, the previously discussed association between size and piecemeal resection has probably resulted in confounding. This is supported by the fact that only one of four studies found size to be associated with risk of recurrence in multivariable analysis. On the other hand, the study by Woodward et al. [64] showed that within categories of en bloc and piecemeal resected lesions, size was still a risk factor. Conversely, piecemeal resection was a risk factor in all three size categories in that study. In addition, Longcroft-Wheaton et al. [67] recently reported that lesion size above 60 mm was a risk factor for recurrence after piecemeal resections.
There is no indication that flat lesions recur more often than sessile lesions, but this may be true for granular vs. nongranular LSTs. The two studies finding no association between granular morphology and recurrence were small compared with the two larger studies that did report an association. However, none of the studies performed multivariable analyses. Piecemeal resection was the only risk factor that was clearly associated with recurrence in multivariable analysis. The risk for recurrence after en bloc resected lesions is indeed small, especially if the pathologist confirms complete resection. As use of APC -in the case of an endoscopically incomplete resection -was no risk factor for recurrence in the current study, additional APC treatment seems to reduce the risk of recurrence so that it is comparable to that after a resection that was endoscopically complete without APC. Two previous studies have shown that APC is an effective additional treatment in case of macroscopic residual tissue after polypectomy [68, 69] . However, in a more recent study by Moss et al. [30] , which included 328 EMRs with follow-up, APC was identified as an independent risk factor for recurrence. We should therefore be careful not to rely too much on APC for complete eradication of neoplastic tissue.
In conclusion, this systematic review and meta-analysis confirms that the risk of local recurrence after piecemeal EMR is significantly higher than after en bloc EMR. A recurrence rate of 20 % justifies performing a follow-up colonoscopy after piecemeal resections, especially because complete clearance can still be achieved in > 90 % of local recurrences after only one endoscopic re-treatment. The optimal timing of the first follow-up colonoscopy remains to be determined in well-scheduled prospective studies, but based on the current data an initial interval of 6 months seems to be more adequate for recurrence detection than an interval of 3 months. Thus far, no risk factors other than piecemeal resection have been identified that can be used to guide a personalized follow-up schedule. Potential bias was scored as follows: + + very small risk; + small risk; ± moderate risk; -high risk. Studies were scored for potential bias from three sources. Study participation: adequate description of: -recruitment, including setting and period -inclusion and exclusion criteria -baseline characteristics of patients and lesions. Study attrition: -numbers and percentages lost to follow-up -adequate description of reasons for loss to follow-up -adequate description of population lost to follow-up and comparison with population in follow-up. Outcome measurement and data reporting: -clear definition of outcome measure -adequate reporting of length of follow-up -use of a fixed follow-up schedule for all patients -adequate reporting of outcome. 1 18 patients without follow-up were excluded from the study. 2 77 patients without follow-up were excluded from the study. 3 Of 373 consecutive lesions between 2000 and 2009, 155 were lost to follow-up. Of 218 remaining cases, 56 were selected. 4 24 patients were excluded from the study, because they were hospitalized in other institutions. 5 32 patients (34 lesions) without follow-up were excluded from the study. 6 151 lesions without follow-up were excluded from the study. 7 54 patients (71 lesions) without follow-up were excluded from the study. 8 26 lesions without follow-up were excluded from the study.
